Merck & Co., Inc. Revenue
Merck & Co., Inc. (MRK) reported Revenue of $16.61 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-07
- Merck & Co., Inc. revenues for the quarter ending 2026-06-30 was $16.61B, a 5.07% increase year-over-year.
- Merck & Co., Inc. revenues for the quarter ending 2026-03-31 was $16.29B, a 4.87% increase year-over-year.
- Merck & Co., Inc. revenues for the quarter ending 2025-12-31 was $16.40B, a 4.97% increase year-over-year.
- Merck & Co., Inc. revenues for the quarter ending 2025-09-30 was $17.28B, a 3.72% increase year-over-year.
- Merck & Co., Inc. revenues for fiscal 2025 was $65.01B, a 1.31% increase from fiscal 2024.
- Merck & Co., Inc. revenues for fiscal 2024 was $64.17B, a 6.74% increase from fiscal 2023.
- Merck & Co., Inc. revenues for fiscal 2023 was $60.12B, a 1.40% increase from fiscal 2022.
- Merck & Co., Inc. revenues for fiscal 2022 was $59.28B, a 21.72% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.61B 10-Q · filed 2026-08-07 | $32.89B 10-Q · filed 2026-08-07 | $49.29B derived: sum of 3 quarters · filed 2026-08-07 | $66.57B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $16.29B 10-Q · filed 2026-05-04 | $32.69B derived: sum of 2 quarters · filed 2026-05-04 | $49.96B derived: sum of 3 quarters · filed 2026-05-04 | $65.77B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | $16.40B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $33.68B derived: sum of 2 quarters · filed 2026-02-24 | $49.48B derived: sum of 3 quarters · filed 2026-08-07 | $65.01B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $17.28B 10-Q · filed 2025-11-05 | $33.08B derived: sum of 2 quarters · filed 2026-08-07 | $48.61B 10-Q · filed 2025-11-05 | $64.23B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $15.81B 10-Q · filed 2026-08-07 | $31.34B 10-Q · filed 2026-08-07 | $46.96B derived: sum of 3 quarters · filed 2026-08-07 | $63.62B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $15.53B 10-Q · filed 2026-05-04 | $31.15B derived: sum of 2 quarters · filed 2026-05-04 | $47.81B derived: sum of 3 quarters · filed 2026-05-04 | $63.92B derived: sum of 4 quarters · filed 2026-05-04 | ||||
| 2024-12-31 | $15.62B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $32.28B derived: sum of 2 quarters · filed 2026-02-24 | $48.39B derived: sum of 3 quarters · filed 2026-02-24 | $64.17B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $16.66B 10-Q · filed 2025-11-05 | $32.77B derived: sum of 2 quarters · filed 2025-11-05 | $48.54B 10-Q · filed 2025-11-05 | $63.17B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $16.11B 10-Q · filed 2025-08-05 | $31.89B 10-Q · filed 2025-08-05 | $46.52B derived: sum of 3 quarters · filed 2026-02-24 | $62.48B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $15.78B 10-Q · filed 2025-05-02 | $30.41B derived: sum of 2 quarters · filed 2026-02-24 | $46.37B derived: sum of 3 quarters · filed 2026-02-24 | $61.40B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $14.63B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $30.59B derived: sum of 2 quarters · filed 2026-02-24 | $45.63B derived: sum of 3 quarters · filed 2026-02-24 | $60.12B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $15.96B 10-Q · filed 2024-11-06 | $31.00B derived: sum of 2 quarters · filed 2024-11-06 | $45.48B 10-Q · filed 2024-11-06 | $59.31B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $15.04B 10-Q · filed 2024-08-05 | $29.52B 10-Q · filed 2024-08-05 | $43.35B derived: sum of 3 quarters · filed 2025-02-25 | $58.31B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $14.49B 10-Q · filed 2024-05-03 | $28.32B derived: sum of 2 quarters · filed 2025-02-25 | $43.28B derived: sum of 3 quarters · filed 2025-02-25 | $57.87B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $13.83B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $28.79B derived: sum of 2 quarters · filed 2025-02-25 | $43.38B derived: sum of 3 quarters · filed 2025-02-25 | $59.28B 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $14.96B 10-Q · filed 2023-11-03 | $29.55B derived: sum of 2 quarters · filed 2023-11-03 | $45.45B 10-Q · filed 2023-11-03 | $58.97B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $14.59B 10-Q · filed 2023-08-07 | $30.49B 10-Q · filed 2023-08-07 | $44.02B derived: sum of 3 quarters · filed 2024-02-26 | $57.17B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $15.90B 10-Q · filed 2023-05-05 | $29.42B derived: sum of 2 quarters · filed 2024-02-26 | $42.58B derived: sum of 3 quarters · filed 2024-02-26 | $53.98B derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $13.52B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $26.68B derived: sum of 2 quarters · filed 2024-02-26 | $38.08B derived: sum of 3 quarters · filed 2024-02-26 | $48.70B 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $13.15B 10-Q · filed 2022-11-03 | $24.56B derived: sum of 2 quarters · filed 2022-11-03 | $35.18B 10-Q · filed 2022-11-03 | $46.13B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $11.40B 10-Q · filed 2022-08-05 | $22.03B 10-Q · filed 2022-08-05 | $32.98B derived: sum of 3 quarters · filed 2023-02-24 | $43.91B derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-03-31 | $10.63B 10-Q · filed 2022-05-05 | $12.08B 10-Q · filed 2021-05-05 | $21.57B derived: sum of 2 quarters · filed 2023-02-24 | $32.50B derived: sum of 3 quarters · filed 2023-02-24 | $41.86B derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $10.95B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $21.88B derived: sum of 2 quarters · filed 2023-02-24 | $31.23B derived: sum of 3 quarters · filed 2023-02-24 | $41.52B 10-K · filed 2023-02-24 | $47.99B 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $10.93B 10-Q · filed 2021-11-05 | $12.55B 10-Q · filed 2020-11-05 | $20.28B derived: sum of 2 quarters · filed 2021-11-05 | $30.57B 10-Q · filed 2021-11-05 | $35.48B 10-Q · filed 2020-11-05 | $36.49B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $9.35B 10-Q · filed 2021-08-09 | $10.87B 10-Q · filed 2020-08-05 | $19.64B 10-Q · filed 2021-08-09 | $22.93B 10-Q · filed 2020-08-05 | $25.56B derived: sum of 3 quarters · filed 2022-02-25 | $37.96B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $12.06B 10-Q · filed 2021-05-05 | $16.21B derived: sum of 2 quarters · filed 2022-02-25 | $28.60B derived: sum of 3 quarters · filed 2022-02-25 | $40.36B derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $4.15B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $16.55B derived: sum of 2 quarters · filed 2022-02-25 | $28.31B derived: sum of 3 quarters · filed 2022-02-25 | $39.12B 10-K · filed 2022-02-25 | $46.84B 10-K · filed 2020-02-26 | |||
| 2019-09-30 | $12.40B 10-Q · filed 2020-11-05 | $24.16B derived: sum of 2 quarters · filed 2020-11-05 | $34.97B 10-Q · filed 2020-11-05 | $45.97B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $11.76B 10-Q · filed 2020-08-05 | $22.57B 10-Q · filed 2020-08-05 | $33.57B derived: sum of 3 quarters · filed 2021-02-25 | $44.37B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $10.82B 10-Q · filed 2020-05-06 | $21.81B derived: sum of 2 quarters · filed 2021-02-25 | $32.61B derived: sum of 3 quarters · filed 2021-02-25 | $43.07B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $11.00B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $21.79B derived: sum of 2 quarters · filed 2021-02-25 | $32.26B derived: sum of 3 quarters · filed 2021-02-25 | $42.29B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $10.79B 10-Q · filed 2019-11-05 | $21.26B derived: sum of 2 quarters · filed 2019-11-05 | $31.30B 10-Q · filed 2019-11-05 | $41.73B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $10.46B 10-Q · filed 2019-08-06 | $20.50B 10-Q · filed 2019-08-06 | $30.93B derived: sum of 3 quarters · filed 2020-02-26 | $41.26B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $10.04B 10-Q · filed 2019-05-08 | $20.47B derived: sum of 2 quarters · filed 2020-02-26 | $30.80B derived: sum of 3 quarters · filed 2020-02-26 | $40.73B derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $10.43B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $20.76B derived: sum of 2 quarters · filed 2020-02-26 | $30.69B derived: sum of 3 quarters · filed 2020-02-26 | $40.12B 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $10.32B 10-Q · filed 2018-11-06 | $20.25B derived: sum of 2 quarters · filed 2018-11-06 | $29.69B 10-Q · filed 2018-11-06 | |||||
| 2017-06-30 | $9.93B 10-Q · filed 2018-08-07 | $19.36B 10-Q · filed 2018-08-07 | ||||||
| 2016-12-31 | $39.81B 10-K · filed 2019-02-27 | |||||||
| 2010-12-31 | $12.09B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $23.22B derived: sum of 2 quarters · filed 2011-02-28 | $34.56B derived: sum of 3 quarters · filed 2011-02-28 | $45.99B 10-K · filed 2011-02-28 | ||||
| 2010-09-30 | $11.12B 10-Q · filed 2010-11-08 | $22.47B derived: sum of 2 quarters · filed 2010-11-08 | $33.89B 10-Q · filed 2010-11-08 | $43.99B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2010-06-30 | $11.35B 10-Q · filed 2010-08-06 | $22.77B 10-Q · filed 2010-08-06 | $32.86B derived: sum of 3 quarters · filed 2011-02-28 | $38.91B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2010-03-31 | $11.42B 10-Q · filed 2010-05-07 | $21.52B derived: sum of 2 quarters · filed 2011-02-28 | $27.57B derived: sum of 3 quarters · filed 2011-02-28 | $33.47B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-12-31 | $10.09B derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $16.14B derived: sum of 2 quarters · filed 2011-02-28 | $22.04B derived: sum of 3 quarters · filed 2011-02-28 | $27.43B 10-K · filed 2011-02-28 | $27.43B 10-K · filed 2010-03-01 | |||
| 2009-09-30 | $6.05B 10-Q · filed 2010-11-08 | $11.95B derived: sum of 2 quarters · filed 2010-11-08 | $17.33B 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $5.90B 10-Q · filed 2010-08-06 | $11.29B 10-Q · filed 2010-08-06 | ||||||
| 2009-03-31 | $5.39B 10-Q · filed 2010-05-07 | |||||||
| 2008-12-31 | $23.85B 10-K · filed 2011-02-28 | $23.85B 10-K · filed 2010-03-01 | ||||||
| 2007-12-31 | $24.20B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |